logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us

Tag: medical

August 7, 2023
by info@virtueinsight.comNews

Carmell to merge with regenerative medicine company Axolotl

    Regenerative medicine company, Carmell Therapeutics, announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix. Axolotl develops, designs, and sells products that are human amnion-based, for...
read more
August 7, 2023
by info@virtueinsight.comNews

Quince Therapeutics To Acquire EryDel

    Quince Therapeutics (Nasdaq: QNCX) in its agreement to acquire EryDel SpA in a stock-for-stock upfront exchange and potential downstream milestone cash payments. Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing...
read more
July 1, 2023
by info@virtueinsight.comNews

Advanco Acquires Vantage Consulting Group

Advanco, established as a global pharmaceutical and life sciences track and trace solutions provider, has announced the acquisition of manufacturing automation specialist Vantage Consulting Group. The company will continue to be called advanco, with an enlarged client portfolio of...
read more
July 1, 2023
by info@virtueinsight.comNews

TraceLink and PharmaLink Partner Up on Simplifying DSCSA Compliance Process

TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink. TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory...
read more
July 1, 2023
by info@virtueinsight.comNews

Tourmaline Bio Agrees To Merge With Talaris Therapeutics

  Talaris Therapeutics, Inc and Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines, announced that the companies have entered into a definitive agreement under which Tourmaline will combine with Talaris in an all-stock...
read more
June 5, 2023
by info@virtueinsight.comNews

Spanish packaging firm Inden Pharma to expand footprint in India

  Spanish packaging firm Inden Pharma is planning to expand its business to India after partnering with Austria-based ALPLApharma that specialises in plastic packaging for pharmaceuticals. In a bid to increase their presence in the global market for pharmaceutical packaging, the...
read more
June 5, 2023
by info@virtueinsight.comNews

EyePoint to sell YUTIQ to Alimera Sciences

      EyePoint Pharmaceuticals (NASDAQ:EYPT) entered into a definitive agreement for the sale of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences. YUTIQ is a treatment for chronic non-infectious uveitis affecting the posterior segment of...
read more
June 5, 2023
by info@virtueinsight.comNews

Juno Pharmaceuticals Acquires Omega Laboratories

  Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers. The new combined company is now...
read more
February 14, 2023
by info@virtueinsight.comNews

Spanish packaging firm Inden Pharma to expand footprint in India

  Spanish packaging firm Inden Pharma is planning to expand its business to India after partnering with Austria-based ALPLApharma that specialises in plastic packaging for pharmaceuticals. In a bid to increase their presence in the global market for pharmaceutical packaging, the...
read more
February 14, 2023
by info@virtueinsight.comNews

EyePoint to sell YUTIQ to Alimera Sciences

      EyePoint Pharmaceuticals (NASDAQ:EYPT) entered into a definitive agreement for the sale of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences. YUTIQ is a treatment for chronic non-infectious uveitis affecting the posterior segment of...
read more
  • 1
  • 2
  • 3
logotype

We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Facebook-fTwitterYoutubeLinkedin-inInstagramPinterest

Quick Links

About us
Contact us
Event Support
Careers
Privacy Policy
Terms & Conditions

Subscribe to our newsletter

    © 2025 Virtue Insight. All rights reserved.